M&A Deal Summary

BioIVT Acquires BeCytes Biotechnologies

On November 4, 2025, BioIVT acquired life science company BeCytes Biotechnologies

Acquisition Highlights
  • This is BioIVT’s 15th transaction in the Life Science sector.
  • This is BioIVT’s 1st transaction in Spain.

M&A Deal Summary

Date 2025-11-04
Target BeCytes Biotechnologies
Sector Life Science
Buyer(s) BioIVT
Deal Type Add-on Acquisition

Target

BeCytes Biotechnologies

Barcelona, Spain
BeCytes Biotechnologies specialises in the coordination of the collection, processing and distribution of high-quality human tissues and cells for biomedical research. BeCytes Biotechnologies was founded in 2018 and is headquartered in Barcelona, Spain.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

BioIVT

Hicksville, New York, United States

Category Company
Founded 1981
Sector Life Science
DESCRIPTION

BioIVT is a provider of biological products to life sciences and pharmaceutical companies. BioIVT specializes in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues, and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. BioIVT was founded in 1981 and is based in Hicksville, New York.


DEAL STATS #
Overall 18 of 18
Sector: Life Science M&A 15 of 15
Type: Add-on Acquisition M&A Deals 17 of 17
Country: Spain M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-08-21 ZenBio

Durham, North Carolina, United States

ZenBio is a provider of advanced cell products and services. ZenBio offers research partners a unique quot;cells and services" model delivering robust cell-based solutions to accelerate the discovery and development of therapies to better the human condition. ZenBio was formed in 1995 and is headquartered in Durham, North Carolina.

Buy -